1 Dead After Clinical Trial Of Experimental Medicine In France

UPDATE 10:50 am: The French health ministry said on Friday that the drug involved in the trial did not contain cannabis, Reuters reports. A person familiar with the situation said the drug was a cannabis-based painkiller in the initial stage of human testing.

 

By Matthias Blamont

PARIS, Jan 15 (Reuters) – One person has been left brain dead and five others have been hospitalized after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on…

CONTINUE READING: Click Here to Continue Reading Article…